The free-living amoebae Naegleria fowleri and Acanthamoeba spp. cause human disease (13) . N. fowleri is responsible for primary amoebic meningoencephalitis (PAM), a fulminating disease characterized by extensive brain tissue destruction after penetration of amoebae to the brain from the nasal passages. Acanthamoeba culbertsoni has been identified in brain sections of humans, where it is responsible for granulomatous amoebic meningoencephalitis in compromised hosts (18, 20) . Another Acanthamoeba species, A. polyphaga, has been associated with ocular infections (14, 15, 17) .
Amphotericin B is the drug of choice in treating Naegleria infections (4, 9, 16, 26) . The amoebae exhibit in vitro sensitivity to the drug (10, 24) . In the few cases when treatment of victims of Naegleria meningoencephalitis was initiated early after diagnosis, amphotericin B was probably instrumental in effecting recovery (1, 2, 25) . The rapid onset of Naegleria PAM, coupled with difficulty in diagnosis, however, has often resulted in delayed start of appropriate chemotherapy, with poor prognosis for recovery (13) . No particular drug therapy has been demonstrably successful in infections involving Acanthamoeba spp., although several have shown promise (7, 21, 23) .
In studying the amoeba-to-flagellate transformation of the nonpathogenic Naegleria gruberi, trifluoperazine was found to have an inhibitory effect on flagellation (24a) as well as on trophic growth of the amoebae. These results prompted the present study of in vitro testing of the antipsychotic phenothiazine agents trifluoperazine dihydrochloride (TFP) and chlorpromazine hydrochloride (CPZ) on the pathogenic amoebae N. fowleri and Acanthamoeba spp. These compounds inhibit the growth of these pathogenic amoebae. MATERIALS prepared as 0.01 M stock solutions in Tris buffer at pH 7.1. Portions of the drugs were added to Naegleria or Acanthamoeba growth media to give concentrations of 10 and 50 ,uM. Drug concentrations of 100 ,uM were also used, but not as a routine part of the experimental design. Equivalents in weight units of the molar concentrations of the two drugs employed in this study are: TFP, 10 p.M (4,800 ng/ml), 50 ,uM (24,000 ng/ml), 100 ,uM (48,000 ng/ml); CPZ, 10 ,uM (3,550 ng/ml), 50 ,uM (17,800 ng/ml), 100 ,uM (35,500 ng/ml). Logarithmic-phase cultures of amoebae served as inocula for growth flasks, and growth was followed for 5 and 8 days for Naegleria and Acanthamoeba sp., respectively. Cell counts were made with a Coulter Counter (model ZF).
Viability testing. Determination of amoebicidal action of a drug concentration was based on viability testing. Inocula from growth flasks were transferred to fresh growth media in screw-cap test tubes, with ca. 50-fold dilution of the drug. Tubes were incubated at 37°C and checked for growth over 10 to 14 days. Absence of growth at that time was taken as a sign of amoebicidal action of that particular drug concentration.
Tissue culture. Rat glioma cells, C6 strain (ATCC CCL107), were inoculated into petri dishes (35 by 100 mm) with HEPES(N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid)-buffered medium 199, with either 5 or 10% newborn calf serum (GIBCO). Twenty-four hours after seeding the plates with C6 cells (2 x 105 to 3 x 105 cells per dish), medium was replaced with fresh medium 199 containing drug concentrations, and the amoeba inoculum (ca. 500 amoebae per dish) was added. Cultures were kept at 37°C and observed for several days.
RESULTS
Concentrations of TFP of 10 ,uM were amoebastatic for both Naegleria sp. and A. culbertsoni for ca. 2 days, but only slightly inhibitory for A. polyphaga. Concentrations of TFP of 50 ,uM were amoebastatic or amoebicidal for Naegleria and Acanthamoeba sp. (Fig. 1 ). The 50 ,uM level appeared to be a threshold; some cultures recovered from exposure to this concentration, whereas others contained only dead cells, as determined by viability testing in growth media. Except for N. fowleri in CPZ, drug concentrations of 100 ,uM were amoebicidal. The effects of the various drug concentrations on amoeba growth are summarized in Table 1 as percent inhibition of growth. Comparison of several pathogenic strains of N. fowleri in 10 ,uM TFP indicated varying sensitivity. NY was least sensitive (<90% inhibition); 0359 and HB-3 were equally inhibited (90 to 95% inhibition); 6088 was most sensitive (>95% inhibition).
It is likely that some breakdown of the drugs was occurring in the growth vessels during the course of the experiments. Introduction of additional portions of, for example, TFP at 24-h intervals to the growth flask maintained the amoebastatic effect at a level greater than the same total drug concentration added at the start of the experiment. This type of continued growth inhibition was more evident in flasks initially exposed to low (10 ,M) than high (50 ,M) drug 20 ,uM TFP. Amoebae are present, but damage to the monolayer caused by feeding is minimal at this point; it took 2 additional days for this dish to reach the condition of the control dish on day 3. Bar, 20,m; x215.
at 1 mM) were added to Naegleria medium containing 10 ,uM TFP. Cholera toxin, known to promote cAMP production __I AM (12) , was also added (1 ,ug/ml) to TFP-inhibited cultures.
None of these agents reversed the rowth inhibition of TFP, nor did the addition of 10 mM Ca + or Mg2+ as chlorides. Added cAMP appeared to enhance the TFP inhibitory effect in Naegleria cultures. Thus, although it is possible that TFP might be interfering with cAMP production in Naegleria sp., the connection has not been demonstrated. Trifluoperazine (and CPZ) may be acting at some other point under the influence of calcium regulatory protein (6) 
